Abstract
The present investigation aimed to isolate the causative agents of onion purple blotch and Stemphylium blight diseases and evaluate the efficacy of certain plant extracts against the two identified pathogens, in vitro and under greenhouse condition. Fourteen isolates of S. vesicarium and two isolates of Alternaria porri were tested for pathogenicity. The results indicated that all isolates were able to produce the symptoms of Stemphylium blight and onion purple blotch diseases with different degrees of severity ranging from 10.42 to 81.25%. A. porri No. 6022 caused the highest disease severity (81.25%), while S. vesicarium No. 6003 was the best one out of the tested 14 isolates (37.5%). Antifungal activity of some aqueous plant extracts (Azadirachta indica, Cydonia oblonga, Datura stramonium, Eucalyptus globulus, Foeniculum vulgare, Ocimum basilicum, Rosmarinus officinalis and Salix mucronata) was assayed in vitro by dry weight technique. The data indicated that there were significant differences between these extracts in their effect on fungal growth of A. porri and S. vesicarium and the best were A. indica and D. stramonium. Under greenhouse conditions, application of the aqueous extract of A. indica either before or after 48 h A. porri inoculation produced the highest reduction in disease severity comprising 70 and 74.7%, respectively. On the other hand, the highest percentage of disease reduction before and after 48 h S. vesicarium inoculation was produced by Ridomil gold plus reached to 84.4 and 95.8% respectively, followed by the aqueous extract of A. indica (74.1 and 89.7, respectively). According to our results, it can be concluded that plant extracts of A. indica and D. stramonium can be used for the biocontrol of purple blotch and Stemphylium blight diseases instead of fungicides to minimise the risks and hazards of using toxic fungicides.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.